Skip to main content Accessibility help
×
Home

Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal

  • Ivana Massabki (a1) and Elia Abi-Jaoude (a2)

Summary

Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term ‘discontinuation syndrome’ are not supported by evidence. Acknowledging that SSRI use can result in dependence and withdrawal allows patients to be better informed around decisions related to these drugs, and helps inform strategies for safe tapering as appropriate.

Copyright

References

Hide All
1Akincigil, A, Olfson, M, Walkup, JT, Siegel, MJ, Kalay, E, Amin, S, et al. Diagnosis and treatment of depression in older community-dwelling adults: 1992–2005. J Am Geriatr Soc 2011; 59(6): 1042–51.
2Bachmann, CJ, Aagaard, L, Burcu, M, Glaeske, G, Kalverdijk, LJ, Petersen, I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012. Eur Neuropsychopharmacol 2016; 26(3): 411–9.
3Lockhart, P, Guthrie, B.Trends in primary care antidepressant prescribing 19952007: a longitudinal population database analysis. Br J Gen Pract 2011; 61(590): 565–72.
4Mojtabai, R.Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008; 77(2): 8392.
5Mojtabai, R, Olfson, M.Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood) 2011; 30(8): 1434–42.
6Pratt, LA, Brody, DJ, Gu, Q. Antidepressant use among persons aged 12 and over: United States, 2011–2014. NCHS Data Brief No. 283, August 2017. Centers for Disease Control and Prevention, 2017 (https://www.cdc.gov/nchs/products/databriefs/db283.htm).
7Moore, M, Yuen, HM, Dunn, N, Mullee, MA, Maskell, J, Kendrick, T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 2009; 339: b3999.
8Cartwright, C, Gibson, K, Read, J, Cowan, O, Dehar, T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence 2016; 10: 1401–7.
9Read, J, Gee, A, Diggle, J, Butler, H. Staying on, and coming off, antidepressants: the experiences of 752 UK adults. Addict Behav 2019; 88: 82–5.
10Stockmann, T, Odegbaro, D, Timimi, S, Moncrieff, J. SSRI and SNRI withdrawal symptoms reported on an internet forum. Int J Risk Saf Med 2018; 29(3–4): 175–80.
11Fava, GA, Gatti, A, Belaise, C, Guidi, J, Offidani, E. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84(2): 7281.
12Nielsen, M, Hansen, EH, Gøtzsche, PC.What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors: SSRi and dependence. Addiction 2012; 107(5): 900–8.
13Davies, J, Read, J.A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav 2019; 97: 111–21.
14Givens, JL, Datto, CJ, Ruckdeschel, K, Knott, K, Zubritsky, C, Oslin, DW, et al. Older patients’ aversion to antidepressants. A qualitative study. J Gen Intern Med 2006; 21(2): 146–51.
15van Schaik, DJF, Klijn, AFJ, van Hout, HPJ, van Marwijk, HW, Beekman, AT, de Haan, M, et al. Patients’ preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004; 26(3): 184–9.
16Read, J, Williams, J.Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects. Curr Drug Saf 2018; 13(3): 176–86.
17Crenson, M. Antidepressants prove addictive to some. The Associated Press, 2006 (http://www.washingtonpost.com/wp-dyn/content/article/2006/08/06/AR2006080600269_pf.html?noredirect=on).
18Tonks, A.Withdrawal from paroxetine can be severe, warns FDA. BMJ 2002; 324(7332): 260.
19Kaplan, EM.Antidepressant noncompliance as a factor in the discontinuation syndrome. J Clin Psychiatry 1997; 58(suppl 7): 31–6.
20Rosenbaum, JF, Zajecka, J.Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997; 58(suppl 7): 3740.
21Schatzberg, AF.Introduction/antidepressant discontinuation syndrome: an update on serotonin reuptake inhibitors. J Clin Psychiatry 1997; 58(suppl 7): 34.
22Schatzberg, AF, Haddad, P, Kaplan, EM, Lejoyeux, M, Rosenbaum, JF, Young, AH, et al. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. J Clin Psychiatry 1997; 58(suppl 7): 510.
23Shelton, RC.The nature of the discontinuation syndrome associated with antidepressant drugs. J Clin Psychiatry 2006; 67(suppl 4): 37.
24National Institute for Health and Care Excellence (NICE). Depression in adults: recognition and management. Clinical guideline CG90. NICE, 2009 (https://www.nice.org.uk/guidance/cg90).
25American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder (revision). APA, 2010 (https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf).
26Black, DW, Wesner, R, Gabel, J.The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993; 54(4): 146–9.
27Haddad, P.Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry 1997; 58(suppl 7): 1721; discussion 22.
28Lejoyeux, M, Adès, J.Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 1997; 58(suppl 7): 11–5; discussion 16.
29Schatzberg, AF, Haddad, P, Kaplan, EM, Lejoyeux, M, Rosenbaum, JF, Young, AH, et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J Clin Psychiatry 1997; 58(suppl 7): 23–7.
30Young, AH, Currie, A.Physicians’ knowledge of antidepressant withdrawal effects: a survey. J Clin Psychiatry 1997; 58(suppl 7): 2830.
31Schatzberg, AF, Haddad, PM, Kaplan, EM, Lejoyeux, M, Rosenbaum, JF, Young, AH, et al. Antidepressant discontinuation syndrome: update on serotonin reuptake inhibitors. J Clin Psychiatry 1997; 58(suppl 7): 340.
32Shelton, RC, Blier, P, Tremblay, P, Fava, M, Delgado, PL, Schatzberg, AF, et al. Antidepressant discontinuation syndrome: current perspectives and consensus recommendations for management. J Clin Psychiatry 2006; 67(suppl. 4): 330.
33Read, J, Cartwright, C, Gibson, K.How many of 1829 antidepressant users report withdrawal effects or addiction? Int J Ment Health Nurs 2018; 27: 1805–15.
34Wilson, E, Lader, M.A review of the management of antidepressant discontinuation symptoms. Ther Adv Psychopharmacol 2015; 5(6): 357–68.
35Rosenbaum, JF, Fava, M, Hoog, SL, Ascroft, RC, Krebs, WB. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44(2): 7787.
36Black, K, Shea, C, Dursun, S, Kutcher, S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000; 25(3): 255–61.
37Haddad, PM.Do antidepressants cause dependence? Epidemiologia e Psichiatria Sociale 2005; 14(02): 5862.
38Baldessarini, RJ, Tondo, L.Effects of treatment discontinuation in clinical psychopharmacology. Psychother Psychosom 2019; 88(2): 6570.
39Royal College of Psychiatrists. Position statement on antidepressants and depression. Royal College of Psychiatrists, 2019 (https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps04_19—antidepressants-and-depression.pdf?sfvrsn=ddea9473_5).
40British Medical Association (BMA). Supporting individuals affected by prescribed drugs associated with dependence and withdrawal. BMA, 2019 (https://www.bma.org.uk/collective-voice/policy-and-research/public-and-population-health/prescribed-drugs-dependence-and-withdrawal).
41Davies, J, Read, J, Hengartner, MP, Cosci, F, Fava, G, Chouinard, G, et al. Clinical guidelines on antidepressant withdrawal urgently need updating. BMJ 2019; 365: I2238.
42Fava, G, Benasi, G, Lucente, M, Offidani, E, Cosci, F, Guidi, J. Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom 2018; 87: 195203.

Keywords

Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal

  • Ivana Massabki (a1) and Elia Abi-Jaoude (a2)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal

  • Ivana Massabki (a1) and Elia Abi-Jaoude (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *